This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovations of Douglas Robinson
Introduction
Douglas Robinson is a prominent inventor based in Cambridge, MA, recognized for his significant contributions to the field of cancer treatment. With a focus on innovative therapies, he has made strides in identifying novel methods for targeting cancer cells.
Latest Patents
Robinson holds a patent titled "Biomarkers for IAP inhibitor therapy." This groundbreaking invention presents a method for selecting subjects with cancer who may benefit from treatment using IAP inhibitors, showcasing Robinson's commitment to advancing cancer therapies.
Career Highlights
Currently, Robinson is employed at Novartis AG, a global healthcare company that focuses on innovative pharmaceuticals. His role at Novartis allows him to contribute to pivotal research and development initiatives aimed at improving patient outcomes in oncology.
Collaborations
Throughout his career, Douglas has worked alongside esteemed colleagues, including Dale Porter and John Scott Cameron. These collaborations highlight the importance of teamwork in the development of effective therapies and the sharing of knowledge within the field.
Conclusion
Douglas Robinson exemplifies the spirit of innovation through his patents and collaborative efforts in cancer research. His work not only contributes to the scientific community but also offers hope for patients seeking effective cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile